Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Depreciation and Depletion (2016 - 2020)

Assembly Biosciences (ASMB) has 6 years of Depreciation and Depletion data on record, last reported at $300000.0 in Q4 2020.

  • For Q4 2020, Depreciation and Depletion rose 200.0% year-over-year to $300000.0; the TTM value through Dec 2020 reached $700000.0, up 40.0%, while the annual FY2023 figure was $500000.0, 0.0% changed from the prior year.
  • Depreciation and Depletion reached $300000.0 in Q4 2020 per ASMB's latest filing, up from $200000.0 in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $300000.0 in Q4 2020 and bottomed at $18000.0 in Q2 2016.
  • Average Depreciation and Depletion over 5 years is $104244.6, with a median of $100000.0 recorded in 2018.
  • Peak YoY movement for Depreciation and Depletion: surged 526.64% in 2018, then plummeted 50.0% in 2019.
  • A 5-year view of Depreciation and Depletion shows it stood at $24750.0 in 2016, then surged by 204.34% to $75324.0 in 2017, then soared by 32.76% to $100000.0 in 2018, then changed by 0.0% to $100000.0 in 2019, then soared by 200.0% to $300000.0 in 2020.
  • Per Business Quant database, its latest 3 readings for Depreciation and Depletion were $300000.0 in Q4 2020, $200000.0 in Q3 2020, and $100000.0 in Q2 2020.